89 related articles for article (PubMed ID: 7786583)
21. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
[TBL] [Abstract][Full Text] [Related]
22. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
23. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys.
Montefiori DC; Baba TW; Li A; Bilska M; Ruprecht RM
J Immunol; 1996 Dec; 157(12):5528-35. PubMed ID: 8955203
[TBL] [Abstract][Full Text] [Related]
24. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
[TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques.
Wagner R; Deml L; Notka F; Wolf H; Schirmbeck R; Reimann J; Teeuwsen V; Heeney J
Intervirology; 1996; 39(1-2):93-103. PubMed ID: 8957675
[TBL] [Abstract][Full Text] [Related]
26. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.
Nakamura M; Takahara Y; Ishii H; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T; Matsuoka S
Microbiol Immunol; 2011 Nov; 55(11):768-73. PubMed ID: 21895748
[TBL] [Abstract][Full Text] [Related]
27. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
28. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
[TBL] [Abstract][Full Text] [Related]
29. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
30. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522
[TBL] [Abstract][Full Text] [Related]
31. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of the vpx, vpr, and nef genes of simian immunodeficiency virus.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):335-44. PubMed ID: 7882097
[TBL] [Abstract][Full Text] [Related]
33. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):333-42. PubMed ID: 8068413
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
[TBL] [Abstract][Full Text] [Related]
35. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
[TBL] [Abstract][Full Text] [Related]
36. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.
Hattori N; Michaels F; Fargnoli K; Marcon L; Gallo RC; Franchini G
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8080-4. PubMed ID: 2236020
[TBL] [Abstract][Full Text] [Related]
37. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
Koup RA; Safrit JT; Cao Y; Andrews CA; McLeod G; Borkowsky W; Farthing C; Ho DD
J Virol; 1994 Jul; 68(7):4650-5. PubMed ID: 8207839
[TBL] [Abstract][Full Text] [Related]
38. HIV-specific cellular and humoral immune responses in primary HIV infection.
Connick E; Marr DG; Zhang XQ; Clark SJ; Saag MS; Schooley RT; Curiel TJ
AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1129-40. PubMed ID: 8844017
[TBL] [Abstract][Full Text] [Related]
39. Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.
Kannagi M; Kiyotaki M; Desrosiers RC; Reimann KA; King NW; Waldron LM; Letvin NL
J Clin Invest; 1986 Nov; 78(5):1229-36. PubMed ID: 3771794
[TBL] [Abstract][Full Text] [Related]
40. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):343-50. PubMed ID: 8068414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
